MedTrace Logo

Chemoradiation-Induced Nausea and Emesis: Quality of Life

NCT00394602 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 207

Last updated 2020-01-02

No results posted yet for this study

Summary

The primary objectives of this study are:

1. To assess the preferences of cancer patients scheduled to receive chemoradiation and caregiver controls for side-effects of chemoradiation.

1. To compare preferences of cancer patients to those of healthy individuals.
2. To compare how patients' preferences for side-effects of chemoradiation change over time.
2. To longitudinally assess the quality of life of cancer patients scheduled to receive chemoradiation.
3. To determine the impact of nausea and vomiting associated with chemoradiation on patients' quality of life and evaluate potential change throughout the duration of chemoradiation treatment.

Conditions

Interventions

BEHAVIORAL

Interview

Interview regarding perceptions of side effects that are related to chemoradiation treatment.

OTHER

Questionnaire

3 Questionnaires regarding quality of life given during and after treatment, each taking about 20 minutes to complete.

Sponsors & Collaborators

Principal Investigators

  • Charlotte C. Sun, MD · M.D. Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-04-07
Primary Completion
2019-05-08
Completion
2019-05-08

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00394602 on ClinicalTrials.gov